These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18841269)

  • 1. Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach.
    Horowitz JD; Chirkov YY
    Thromb Haemost; 2008 Oct; 100(4):519-20. PubMed ID: 18841269
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary use of clopidogrel in patients with coronary artery disease.
    Parikh SA; Beckman JA
    Curr Cardiol Rep; 2007 Jul; 9(4):257-63. PubMed ID: 17601391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
    Granitskiĭ NA
    Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel versus ticlopidine after the placement of coronary artery stents.
    Rott D
    J Am Coll Cardiol; 2003 Aug; 42(4):772; author reply 772-3. PubMed ID: 12932620
    [No Abstract]   [Full Text] [Related]  

  • 5. A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance.
    Lee JS; Dunn SP; Marshall HM; Cohen MG; Smyth SS
    Clin Cardiol; 2007 Apr; 30(4):200-3. PubMed ID: 17443655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation.
    Joyal D; Rudski L
    J Invasive Cardiol; 2007 Sep; 19(9):E265-7. PubMed ID: 17827517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CHARISMA trial and the REACH registry outcomes.
    Faxon DP; Nesto RW
    J Natl Med Assoc; 2006 Oct; 98(10):1713. PubMed ID: 17052070
    [No Abstract]   [Full Text] [Related]  

  • 8. Stent thrombosis in a clopidogrel nonresponder.
    Laird PA; Ruppert SD
    Crit Care Nurs Q; 2012; 35(2):151-9. PubMed ID: 22407371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
    Kim YS; Lee SR
    Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.
    Mendolicchio GL; Zavalloni D; Bacci M; Roveda M; Quagliuolo V; Anselmi CV; Rota LL; Ruggeri ZM
    Thromb Haemost; 2015 Mar; 113(3):664-7. PubMed ID: 25428265
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical, biochemical and genetical resistance to clopidogrel in a patient with recurrent stent thrombosis.
    van Werkum JW; Heestermans AA; Plokker HW; ten Berg JM
    Int J Cardiol; 2007 Mar; 116(1):136-7; author reply 134-5. PubMed ID: 16870279
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?
    Samoš M; Fedor M; Kovář F; Duraj L; Stančiaková L; Galajda P; Staško J; Kubisz P; Mokáň M
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):117-20. PubMed ID: 26340464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
    Milicic D; Skoric B; Lovric D
    J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine.
    Almsherqi ZA; McLachlan CS; Mossop P; Deng Y
    Int J Cardiol; 2007 Jan; 114(1):101-2. PubMed ID: 16343664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent thrombosis: patient card on discontinuing clopidogrel is available.
    Antoniou S; Rothman MT
    BMJ; 2007 Jan; 334(7584):57. PubMed ID: 17218674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Late coronary stent thrombosis and clopidogrel].
    Varvarovský I; Matejka J; Herman A
    Vnitr Lek; 2007 Oct; 53(10):1085-91. PubMed ID: 18072434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
    de Carvalho HC
    Rev Port Cardiol; 1999 Jun; 18(6):657-8. PubMed ID: 10422464
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of clopidrogel in coronary stenting: what was the question?
    Klein LW; Calvin JE
    J Am Coll Cardiol; 1999 Dec; 34(7):1895-8. PubMed ID: 10588200
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting versus bare-metal stents: when and for whom?
    Beyar R; Nikolsky E
    J Invasive Cardiol; 2008 Mar; 20(3):105-6. PubMed ID: 18316824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.